Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair(®) versus HandiHaler(®) in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial

PURPOSE: To compare the bronchodilator efficacy of 18 μg once-daily tiotropium inhalation administered via Discair(®) versus HandiHaler(®) in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD). PATIENTS AND METHODS: Fifty-eight patients with moderate-to-severe COPD were enro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yildiz, Pinar, Bayraktaroglu, Mesut, Gorgun, Didem, Secik, Funda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125983/
https://www.ncbi.nlm.nih.gov/pubmed/27920513
http://dx.doi.org/10.2147/COPD.S119114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125983/
https://www.ncbi.nlm.nih.gov/pubmed/27920513
http://dx.doi.org/10.2147/COPD.S119114

Ejemplares similares